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Abstract
Objective—This article reviews literature on adults’ mental health outcomes during acute and 
long-term colorectal cancer (CRC) survivorship.
Methods—We identified articles that included at least one measure of psychological symptoms 
or mental quality of life or well-being through a search of databases (CINAHL, MEDLINE, 
PsycINFO, and PsycARTICLES). Articles were published between January 2004 and April 2015.
Results—A significant proportion of CRC survivors experience clinically meaningful levels of 
anxiety and depressive symptoms or reduced mental well-being across the trajectory of the illness. 
Demographic, medical, and psychosocial predictors of mental health outcomes were identified. 
However, few studies were theory-driven, and gaps remain in our understanding of risk and 
protective factors with respect to mental health outcomes, especially during long-term CRC 
survivorship.
Conclusions—Theory-driven longitudinal research with larger samples is required to identify 
subgroups of CRC survivors with different trajectories of psychological adjustment. Such research 
would assess adjustment as a function of internal resources (e.g., personality, coping) and external 
resources (e.g., finances, social support) to inform future interventions for CRC survivors.
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Colorectal cancer (CRC) is the third most common cancer affecting both men and women in 
the United States, with over 132,000 new cases expected in 2015 [1]. CRC includes 
malignancies of the colon and rectum for which the majority of patients receive surgery. 
Chemotherapy alone, or in combination with radiation, also is administered before or after 
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surgery to most patients whose cancer has deeply invaded the bowel wall or metastasized to 
lymph nodes [1]. Additionally, since 2004, several targeted therapies have received FDA 
approval for the treatment of metastatic CRC [1].
Treatment of CRC results in cure in the majority of affected patients [1], and survivors of 
this disease often experience a range of medical, practical, and social challenges, which 
impact their mental well-being. Literature on mental health following a CRC diagnosis and 
treatment has proliferated in recent years. A critical examination of this literature is essential 
for guiding future research and informing clinical care.
This review of mental health in CRC survivors is limited to articles published in English 
between January 1, 2004 and April 28, 2015. We focus on these more recent studies because 
they are more likely to reflect current practice in CRC treatment and longer survival and 
show methodological improvement relative to earlier studies. Articles were identified 
through a search of CINAHL, MEDLINE, PsycINFO, and PsycARTICLES. Search terms 
used in each database included combinations of cancer (including oncolog*, neoplasm), 
colorectal (including colon, rectal), and terms related to quality of life (including distress, 
psycho*, anxiety, depress*, *traumatic stress, “psychological stress,” stress, emotion*, 
“mental health,” worry, fear, stigma, identity, adjustment, adaptation, well-being, symptoms, 
pain, fatigue, dyspnea, breath*, sleep, sexual, urinary incontinence).
Several criteria were used to guide article selection for this review. Articles had to be 
published in refereed journals and had to include at least one validated measure of 
psychological symptoms or mental quality of life (QOL) or well-being. In addition, study 
participants had to be adult CRC patients or survivors of any disease stage. We excluded 
articles that focused on interventions for CRC survivors because this research is beyond the 
scope of this review.
First, we review the literature on mental health during the acute survivorship period, 
beginning around the time of diagnosis and treatment and continuing 1 to 2 years post-
diagnosis. Then we review the literature on mental health during the middle- to long-term 
survivorship periods, which generally begin around 2 years post-diagnosis. Illustrative 
studies for the acute and long-term CRC survivorship periods are summarized in Tables 1 
and 2, respectively. Finally, we provide a methodological and conceptual critique of prior 
research along with directions for future research.
Mental Health during the Acute Survivorship Period
Anxiety and Depressive Symptoms
The prevalence of CRC patients’ anxiety and depressive symptoms during the acute 
survivorship period, defined as 1 to 2 years post-diagnosis, has varied across studies. For 
example, a U.S. study found that 13% of CRC patients at 3 to 6 months post-diagnosis 
reported moderate to severe depressive symptoms on the Center for Epidemiologic Studies 
Depression Scale-8 (CES-D-8) [2]. Another study in Australia found a low prevalence of 
significant anxiety and depressive symptoms on the Brief Symptom Inventory-18 (BSI-18) 
at 6 and 12 months following CRC diagnosis (range = 7% to 8%) [3]. In contrast, a cross-
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sectional study of patients in Southern England who had been diagnosed with CRC during 
the past year found that 19% showed significant anxiety and 14% showed significant 
depressive symptoms on the Hospital Anxiety and Depression Scale (HADS) [4].
Trajectories of anxiety and depressive symptoms during the acute survivorship period have 
not been well characterized. Some exceptions are discussed here. First, a study of CRC 
patients in Taiwan found that anxiety and depressive symptoms on the Memorial Symptom 
Assessment Scale worsened at 1 month following the diagnosis and then returned to baseline 
levels at 3 and 6 months post-diagnosis [5]. Conversely, a study in the U.S. and Canada did 
not find fluctuations in depressive symptoms on the CES-D, which remained at low levels 
prior to CRC surgery and at 6-, 12-, and 18-months post-surgery [6]. In a study in Hong 
Kong, the HADS was administered to CRC patients within 12 weeks of diagnosis and at 3- 
and 12-month follow-ups [7]. Results indicated that the majority of patients (65–67%) 
showed a resilient trajectory, whereas a fraction showed recovery (13–16%) or delayed 
distress (10–13%) trajectories. A small minority of patients (7–9%) showed a chronic 
distress trajectory. Taken together, studies suggest that most patients are within the 
normative range with respect to anxiety and depressive symptoms during the acute 
survivorship period. However, these studies did not assess cancer-specific distress (e.g., 
worry, posttraumatic stress symptoms), which is elevated in some patients who do not show 
generalized psychological distress.
Emotional Functioning
Other longitudinal studies have documented changes in emotional functioning on 
standardized QOL instruments during the acute survivorship period. For example, a 
Japanese study of CRC patients found that emotional functioning on the European 
Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 improved between 
the time prior to surgery and 1–4 months post-surgery [8]. In contrast, Swedish and German 
studies of rectal cancer patients undergoing surgery found that emotional functioning 
declined during the acute recovery period (i.e., pre-surgery to discharge or 1 month post-
surgery) but then improved at follow-ups of 6 and 24 months, respectively [9, 10]. A Danish 
study documented changes in emotional functioning on the EORTC QLQ-C30 every 3 
months for 24 months following complex rectal cancer surgery [11]. Emotional functioning 
showed a clinically significant improvement at 12 months post-surgery and then remained 
stable.
Other studies have examined the emotional functioning of CRC patients undergoing 
adjuvant treatments. For example, a study in the U.S. prospectively examined change in 
emotional well-being among locally advanced rectal cancer patients receiving neoadjuvant 
chemoradiation [12]. Emotional functioning on the EORTC QLQ-C30 did not change over 
the three studied time points (3 weeks pre-treatment, week 4 of chemoradiation, and 1 
month post-chemoradiation). Another U.S. study of CRC patients receiving various 
treatments found that emotional well-being on the Functional Assessment of Cancer 
Therapy-Colorectal exceeded population norms at an average of 9 months post-diagnosis 
[13]. Subsequently, equal numbers of patients showed clinically meaningful decline (26%) 
or improvement (26%) in emotional well-being at 19 months. Given differences in patient 
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characteristics, time points, and measures used in these studies, further research is needed 
before drawing definitive conclusions regarding the trajectory of emotional functioning of 
CRC survivors in the acute survivorship period.
Correlates of Mental Health Outcomes
Demographic and medical correlates of mental health outcomes during the acute 
survivorship period have been identified. First, lower socioeconomic status and younger age 
have been associated with greater anxiety and depressive symptoms and worse emotional 
well-being [4, 7, 14–19]. One study found depressive symptoms to be stable during the first 
18 months post-surgery for CRC, but consistently higher among younger adults than older 
adults [6]. Furthermore, older adults reported more rapid declines in negative affect than 
younger adults. Other demographic factors, including gender and marital status, have shown 
mixed associations with CRC patients’ psychological adjustment [4, 6, 7, 15, 20]. Regarding 
medical factors, greater medical comorbidities, worse self-reported general health, bowel 
dysfunction, and physical symptom distress have been correlated with worse psychological 
outcomes [3, 13, 16, 18, 21]. However, CRC stage has shown mixed associations with 
distress [2–4, 15, 19, 20, 22], and time since diagnosis was unrelated to distress in several 
studies [4, 15, 20].
One medical factor expected to result in greater distress is the presence of a stoma; however, 
limited research has examined its relation to psychological outcomes [19, 23, 24]. One 
longitudinal study of CRC patients from 3 to 24 months post-surgery found that stoma 
patients had higher levels of depressive symptoms than non-stoma patients [24]. 
Additionally, results from this study suggested that having a stoma made some time after the 
primary operation was more distressing than having a stoma made during the initial 
operation. Stoma status and other medical variables (e.g., cancer type, receipt of 
chemotherapy) warrant further study before conclusions may be drawn regarding their 
impact on mental health.
Psychosocial resources associated with better psychological adjustment to CRC in the acute 
survivorship period have included higher levels of optimism [3, 18, 25], reduced cancer 
threat appraisal [3, 6, 25], greater social support [3, 18], and better family relationship 
quality [16]. In addition, among Chinese CRC patients, greater personal control and 
collective control (i.e., control over cancer-related problems in collaboration with close 
others) were associated with lower levels of depressive symptoms [16]. Conversely, greater 
rumination was found to be a risk factor for depressive symptoms in Danish colon cancer 
patients [20]. All of these findings are consistent with other medical and general population 
literatures on risk and protective factors with respect to mental health [26, 27].
Mental Health during the Long-term Survivorship Period
Anxiety and Depressive Symptoms
Few studies have focused on anxiety and depressive symptoms among long-term CRC 
survivors, defined as those who are two or more years post-diagnosis [28–30]. One example 
is an Australian study of CRC survivors which found that the prevalence of clinically 
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significant distress (i.e., anxiety, depressive symptoms, and somatization) on the BSI-18 was 
40% at 2 years post-diagnosis and 42% at 5 years post-diagnosis [28]. However, when the 
authors used a more stringent cutoff on the BSI-18, only 5% reported significant distress at 5 
years post-diagnosis [31]. Four subgroups of survivors were identified, ranging from those 
with consistently low distress (19%) to those with high distress that gradually decreased over 
the 5 years post-diagnosis (13%) [28]. The largest group of survivors (39%) showed 
moderate levels of distress that steadily increased to clinically significant levels over the 5 
years post-diagnosis. The authors did not collect sufficient information to ascertain reasons 
for this increase in distress, such as disease recurrence or progression. Another study in 
Japan found that 37% of CRC survivors showed significant depressive symptoms and 8% 
showed significant anxiety on the HADS at an average of 40 months post-surgery [29]. 
Taken together, findings suggest that a significant proportion of long-term CRC survivors 
experience meaningful levels of anxiety and depressive symptoms.
Emotional Functioning
Other studies have used standardized QOL instruments to document emotional functioning 
among long-term CRC survivors. A population-based German study found that, at 3, 5, and 
10 years post-diagnosis, CRC survivors showed deficits in emotional functioning relative to 
the general population on the EORTC QLQ-C30 [32, 33]. Moreover, survivors’ emotional 
functioning significantly worsened over the 10-year study period. Similarly, an Italian study 
found that 5-year CRC survivors, all of whom underwent curative surgery, reported 
significantly worse mental health on the Short Form 36 Health Survey (SF-36) relative to the 
general population [34]. On the other hand, a few studies have found comparable or better 
emotional functioning among long-term CRC survivors relative to non-cancer controls [35, 
36]. For example, a cross-sectional, population-based study in France recruited three groups 
of CRC survivors based on survival period (i.e., 5, 10, and 15 years post-diagnosis) and non-
cancer controls [35]. No differences in mental health outcomes on the SF-36 and EORTC 
QLQ-C30 were found between the three groups of CRC survivors and controls. Finally, a 
population-based study in the Netherlands found that colon cancer survivors who were, on 
average, 4 years post-diagnosis reported better mental health and fewer role limitations due 
to emotional problems on the SF-36 relative to norms [36].
Correlates of Mental Health Outcomes
Although methodological differences may partially explain disparate findings across studies, 
evidence suggests that demographic characteristics also account for variance in mental 
health outcomes [28, 33, 37]. One prospective population-based study of CRC survivors in 
Australia found that certain patient characteristics (e.g., male gender, younger age, lower 
levels of education) predicted consistently high global distress on the BSI-18 up to 5 years 
post-diagnosis [28]. Other studies have documented trajectories of emotional functioning by 
gender or age group during long-term CRC survivorship. For example, a longitudinal U.S. 
study of rectal cancer patients found that mental health on the SF-36 did not significantly 
vary by gender during a 5-year period following surgery [38]. However, women showed 
improvement in mental health over time, whereas men’s mental health did not change over 
the 5-year period. Another longitudinal study found that younger German CRC survivors 
(age at diagnosis < 60 years) consistently reported reduced emotional functioning on the 
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EORTC QLQ-C30 relative to general population controls during the 10 years after diagnosis 
[33]. In contrast, older CRC survivors’ (age at diagnosis ≥ 70 years) emotional functioning 
did not differ from that of controls during the first 5 years post-diagnosis and then became 
worse than controls at 10 years post-diagnosis. Thus, decrements in emotional functioning in 
older survivors only became evident during long-term follow-up.
Other studies have focused on medical and psychological predictors of mental health 
outcomes in long-term CRC survivors. Studied medical predictors have included stoma 
status, disease stage, tumor location, and cancer treatment [28, 39–42]. Research on stoma 
status has yielded mixed results [39–42]. Several studies of long-term (mean/median = 3–13 
years post-treatment) rectal cancer survivors found that emotional functioning on the 
EORTC QLQ-C30 did not differ as a function of stoma status [39–41]. However, another 
study examined rectal cancer survivors at an average of 11 years post-surgery and found that 
male and female survivors with a permanent stoma reported worse mental health on the 
SF-36 than controls without a stoma [42]. The relation of disease stage to mental health 
outcomes has rarely been examined in long-term CRC survivors. One study found that late 
disease stage predicted high global distress on the BSI-18 up to 5 years following CRC 
diagnosis [28]. Tumor location and treatment-related factors (i.e., receipt of 
chemoradiotherapy, presence of surgical complications) have not been found to predict 
emotional functioning in long-term rectal cancer survivors [39, 41]; however, studies 
examining such relationships are scarce. Finally, psychological factors, including lower 
levels of optimism and disease acceptance and higher levels of helplessness, have predicted 
emotional well-being and anxiety and depressive symptoms in long-term CRC survivors [31, 
40]. As longitudinal research with long-term CRC survivors is limited, further research is 
needed to establish demographic, medical, and psychological predictors of their mental 
health outcomes.
Methodological Critique
Although a growing number of longitudinal studies have assessed mental health outcomes at 
several time points following CRC diagnosis or treatment, many studies are cross-sectional 
and include patients at various times since diagnosis. In addition, the percentages of CRC 
patients currently undergoing different types of treatment are often not reported. 
Furthermore, many studies do not examine important medical factors that may predict 
distress such as surgery type (laparoscopic vs. open), adjuvant treatment type (chemotherapy 
vs. none, chemoradiotherapy), cancer location (colon vs. rectal), or disease stage. Sampling 
CRC patients at different phases of the illness trajectory (e.g., diagnosis, treatment, 
survivorship, recurrence, palliative phase) would allow us to identify distressed subgroups. 
For example, a cross-sectional study in Finland included five groups of CRC patients: 
primary treatment, rehabilitation, remission, metastatic disease, and palliative care [43]. 
Relative to the general population, depressive symptoms were only found to be greater for 
the metastatic disease and palliative care groups. To date, scarce research has focused on the 
palliative care phase of CRC. Studying patients at all phases of the illness, increasing sample 
size for subgroup analyses, and providing a detailed account of prior and current treatments 
are important steps for future research.
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Demographic diversity also warrants greater attention in the design and reporting of future 
work. To date, survivorship studies have primarily been conducted in Asia, Europe, 
Australia, Canada, and the U.S. The majority of patients in CRC studies have been 
Caucasian, and the ethnicity of minority patients is often not reported. Race and ethnicity 
have been associated with health-related coping strategies [44], explanations of illness [45], 
health literacy [46], and patient-provider communication [47]; thus, cross-cultural studies 
would elucidate the role of context and culture-specific beliefs in psychological adjustment 
to CRC. Increased incorporation of social class data (e.g., education, income) would allow 
researchers to examine the intersection of economic and cultural factors on mental health 
outcomes.
Inconsistency in measurement methodology is another major issue that deserves attention in 
future research. Although the EORTC QLQ-C30 has been commonly used in studies of 
CRC patients, researchers have generally relied on diverse instruments to assess QOL and 
anxiety and depressive symptoms in this population. Although most of these instruments 
have evidence of reliability and validity, their infrequent use does not allow for comparisons 
across CRC studies. In an effort to standardize self-report assessments of patient health 
outcomes across studies, the National Institutes of Health (NIH) funded the development of 
the Patient Reported Outcomes Measurement Information System (PROMIS). These 
measures have undergone rigorous reliability and validity testing [48, 49] and have been 
translated into a number of languages. Additionally, standardized T-scores allow 
comparisons with general population norms. Cancer patients provided input during the 
measure development process [50], and a growing body of research has documented the 
measures’ reliability and validity for use with cancer patients [51, 52]. Greater use of these 
measures with CRC patients may facilitate reporting of clinically meaningful symptom 
change and aggregation of results across studies.
Conceptual Critique
Understudied Mental Health Outcomes
Although studies have documented general anxiety and depressive symptoms in CRC 
survivors [2, 3], cancer-specific distress, such as cancer-related posttraumatic stress disorder 
(PTSD), has received little attention in this population [53]. PTSD symptoms include 
intrusive thoughts or re-experiencing cancer-related trauma, avoidance of internal or external 
reminders of the trauma, negative changes in cognition or mood, and hyperarousal [54]. A 
recent meta-analysis found an average prevalence of 6% for cancer-related PTSD and 13% 
for lifetime cancer-related PTSD across studies of various cancer types using clinical 
interview methods [55]. Additionally, younger age and more advanced disease were 
associated with a higher prevalence of current cancer-related PTSD. Results of another 
meta-analysis suggested that cancer-related PTSD symptoms are associated with greater 
general distress symptoms, reduced social support, and poorer physical QOL across cancer 
types [56]. The degree to which the prevalence and correlates of PTSD differ for CRC 
survivors relative to other cancer populations is largely unknown. Studies informed by 
theoretical models of PTSD [57] are needed to determine whether clinical characteristics of 
CRC (e.g., stoma, surgery type) are associated with PTSD.
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Another type of cancer-specific distress that has received scarce attention in the CRC 
literature is fear of cancer recurrence (FCR). Although definitions of FCR vary, it is 
generally defined as fear or worry that cancer will return or progress [58]. In a systematic 
review, survivors were found to report low to moderate levels of FCR, but it was rated as one 
of their greatest concerns [59]. Another systematic review found that younger age and 
greater physical symptoms and psychological distress were associated with greater FCR 
[60]. Despite the growth of research on FCR, key conceptual and methodological issues 
warrant further study. Developing a consensual definition of FCR and rapid screening tools 
with clinical cutoffs are important next steps. In addition, although a cognitive-behavioral 
model of FCR has been proposed [61], no theoretical model has been tested using rigorous, 
prospective designs. Identifying theory-driven predictors of FCR among CRC and other 
cancer survivors would inform intervention development.
Other cancer-related worries also have rarely been studied in CRC populations. For example, 
one study of over 5,000 CRC and lung cancer patients found a high prevalence of worries 
associated with treatment decision-making [62]. Specifically, over 75% of patients worried 
about side effects of treatment and 40% worried about the cost of treatment. In addition, 
52% worried about time away from work and 50% worried about time away from family. 
Longitudinal studies are needed to identify the types of cancer-related worry that are most 
common at different points in the CRC trajectory and their predictors.
Potential Theoretical Frameworks
Use of a theoretical framework may inform hypothesis testing and measurement selection; 
however, most studies on mental health in CRC survivors are not guided by theory. 
Exceptions to this trend include research with acute CRC survivors framed by conservation 
of resources theory [7, 15]. According to this theory, changes in internal and external 
resources drive adaptation to stressors such as cancer [63]. Internal resources include 
personality factors such as optimism, a sense of mastery or control over circumstances, and 
self-esteem [64]. External resources are derived from the physical environment or 
interactions with others and include finances, employment, and social support [65]. From 
this perspective, preventing resource depletion and maintaining or gaining resources should 
promote healthy psychological adjustment to stress [63]. Future longitudinal research with 
CRC survivors should consider incorporating relevant internal and external resources as 
predictors of adjustment outcomes.
Psychological adjustment to CRC may also be understood within the stress and coping 
framework of Lazarus and Folkman [66]. According to this framework, when an internal or 
external demand is appraised as exceeding the person’s resources, the demand is considered 
a stressor. The process of coping with stressors affects psychological well-being. Using this 
framework, future research may examine coping efforts of CRC survivors and the contexts 
in which these efforts are adaptive. For example, adaptive coping efforts in a palliative care 
context are likely to differ from those in a long-term survivorship context.
Stigma theory [67, 68] may also be a useful framework for understanding CRC survivors’ 
coping and mental health outcomes. Survivors may perceive CRC as stigmatizing for a 
number of reasons. First, some CRC survivors have a colostomy or ileostomy which may 
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limit social interaction [69] and prompt reactions of disgust [70]. Indeed, rectal cancer 
survivors with a stoma feel more stigmatized [71], experience worse social well-being, and 
report greater symptoms of depression than those without a stoma [42]. Second, 
incontinence and other defecation-related problems may contribute to body image 
disturbances and impaired QOL [72]. Third, CRC survivors may have difficulty adapting to 
physical limitations, changes in roles (e.g., loss of ability to work) [73], and altered sexual 
functioning [74], all of which may increase perceptions of stigma. Furthermore, the “cancer 
patient” role is associated with disability and death and, thus, is likely to be stigmatized or 
devalued by others [75]. Finally, men have voiced concerns that colonoscopy or 
examinations of the rectum are embarrassing or a threat to masculine identity, thereby 
increasing their perceptions of stigma [76, 77]. In support of stigma theory, a U.S. study of 
male veterans with CRC found that 31% endorsed at least one item assessing cancer-related 
stigma, and 25% reported some degree of self-blame with respect to their illness [78]. In 
cross-sectional analyses, cancer stigma and self-blame were positively associated with 
depressive symptoms. Further studies with more diverse samples are needed to determine 
the extent to which CRC survivors perceive stigma and its association with mental health 
outcomes.
Finally, as the majority of CRC survivors exhibit resilience with respect to psychological 
adjustment, it is important to identify factors that promote positive mental health outcomes. 
For example, the strength and vulnerability integration model (SAVI) may be used to 
understand older adults’ greater psychological resilience relative to younger adults [79]. This 
model posits that age differences in distress are small at the time of a negative event (e.g., 
cancer diagnosis) and then increase over time. Explanations for this trend include the greater 
use of adaptive emotion regulation strategies among older adults. For example, older adults’ 
appraisals of events and recollections of experiences are less negative than those of younger 
adults, and these cognitive strategies may lead to reduced negative mood [80]. One 
longitudinal study largely supported this model in a CRC population [6]. Specifically, older 
adults reported more rapid declines in negative affect than younger adults during the first 18 
months after CRC surgery, and this age difference was mediated by older adults’ more 
adaptive appraisals of the cancer experience. Greater understanding of individual and 
contextual factors that contribute to positive psychological sequelae (e.g., perceived personal 
growth, positive emotions) in CRC survivors would contribute to theory and intervention 
development [25, 53].
Conclusions
Accumulating evidence suggests that a significant minority of CRC survivors experience 
clinically meaningful distress across the trajectory of the illness. Theory-driven longitudinal 
research is needed to identify predictors of cancer-specific distress and general mental health 
outcomes in this population. Patterns of psychological adjustment could also be identified 
and compared at various points in the illness trajectory. Enrolling larger samples with greater 
demographic and medical diversity will enable subgroup comparisons and enhance 
generalizability of findings. Incorporating standardized mental health measures (e.g., NIH 
PROMIS measures) will facilitate comparisons across studies. Ultimately, such research will 
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inform tailored interventions to prevent and reduce poor mental health outcomes in this 
growing population of cancer survivors.
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